Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 11/2012

01.11.2012 | Article

Spread of an OmpK36-modified ST15 Klebsiella pneumoniae variant during an outbreak involving multiple carbapenem-resistant Enterobacteriaceae species and clones

verfasst von: Â. Novais, C. Rodrigues, R. Branquinho, P. Antunes, F. Grosso, L. Boaventura, G. Ribeiro, L. Peixe

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 11/2012

Einloggen, um Zugang zu erhalten

Abstract

We aim to characterise multiple ertapenem-resistant (ERT-R, n = 15) Enterobacteriaceae isolates identified as presumptive carbapenemase producers in a Portuguese hospital in a short period of time (March–July 2010). Antibiotic susceptibility patterns, β-lactamases, genetic relatedness [pulsed-field gel electrophoresis (PFGE), multi-locus sequence typing (MLST)], plasmid content and major enterobacterial porins were investigated. Ertapenem resistance was associated with deficiencies in major porins and, in some cases, extended-spectrum β-lactamase (ESBL) or AmpC β-lactamase production among outbreak and non-outbreak clones. Most isolates (n = 8) corresponded to two ERT-R Klebsiella pneumoniae ST15 PFGE-types: (i) a sporadic variant (Kp-A-ERT, n = 1) presenting a premature stop codon in ompK36 and (ii) an epidemic variant (Kp-B-ERT, n = 7) exhibiting a new OmpK36 porin variant, which differed additionally in plasmid and antibiotic susceptibility profiles. ST14 (n = 1) and ST45 (n = 1) K. pneumoniae, ST131 (n = 1) and ST354 (n = 1) Escherichia coli, Enterobacter asburiae (n = 1), Enterobacter cloacae (n = 1) and Enterobacter aerogenes (n = 1) ERT-R clones were also sporadically detected. Porin changes in these isolates included non-sense mutations [ompK35, ompK36, ompF; minimum inhibitory concentration (MIC) = 4–32 mg/l], IS-mediated porin disruptions (ompK36, ompC; MIC = 12–>32 mg/l) or alterations in the L3 loop (ompK36; MIC = 4–16 mg/l). We describe, for the first time in Portugal, the simultaneous emergence of multiple ERT-R Enterobacteriaceae species and clones in a short period of time. Moreover, our results support that a CTX-M-15-producing ST15 K. pneumoniae with an OmpK36-modified porin might successfully spread in the nosocomial setting.
Literatur
1.
Zurück zum Zitat Pfeifer Y, Cullik A, Witte W (2010) Resistance to cephalosporins and carbapenems in Gram-negative bacterial pathogens. Int J Med Microbiol 300(6):371–379PubMedCrossRef Pfeifer Y, Cullik A, Witte W (2010) Resistance to cephalosporins and carbapenems in Gram-negative bacterial pathogens. Int J Med Microbiol 300(6):371–379PubMedCrossRef
2.
Zurück zum Zitat Nordmann P, Naas T, Poirel L (2011) Global spread of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis 17(10):1791–1798PubMedCrossRef Nordmann P, Naas T, Poirel L (2011) Global spread of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis 17(10):1791–1798PubMedCrossRef
3.
Zurück zum Zitat Doumith M, Ellington MJ, Livermore DM, Woodford N (2009) Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK. J Antimicrob Chemother 63(4):659–667PubMedCrossRef Doumith M, Ellington MJ, Livermore DM, Woodford N (2009) Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK. J Antimicrob Chemother 63(4):659–667PubMedCrossRef
4.
Zurück zum Zitat García-Fernández A, Miriagou V, Papagiannitsis CC, Giordano A, Venditti M, Mancini C, Carattoli A (2010) An ertapenem-resistant extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae clone carries a novel OmpK36 porin variant. Antimicrob Agents Chemother 54(10):4178–4184PubMedCrossRef García-Fernández A, Miriagou V, Papagiannitsis CC, Giordano A, Venditti M, Mancini C, Carattoli A (2010) An ertapenem-resistant extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae clone carries a novel OmpK36 porin variant. Antimicrob Agents Chemother 54(10):4178–4184PubMedCrossRef
5.
Zurück zum Zitat Kaczmarek FM, Dib-Hajj F, Shang W, Gootz TD (2006) High-level carbapenem resistance in a Klebsiella pneumoniae clinical isolate is due to the combination of bla(ACT-1) beta-lactamase production, porin OmpK35/36 insertional inactivation, and down-regulation of the phosphate transport porin phoE. Antimicrob Agents Chemother 50(10):3396–3406PubMedCrossRef Kaczmarek FM, Dib-Hajj F, Shang W, Gootz TD (2006) High-level carbapenem resistance in a Klebsiella pneumoniae clinical isolate is due to the combination of bla(ACT-1) beta-lactamase production, porin OmpK35/36 insertional inactivation, and down-regulation of the phosphate transport porin phoE. Antimicrob Agents Chemother 50(10):3396–3406PubMedCrossRef
6.
Zurück zum Zitat Cuzon G, Naas T, Guibert M, Nordmann P (2010) In vivo selection of imipenem-resistant Klebsiella pneumoniae producing extended-spectrum beta-lactamase CTX-M-15 and plasmid-encoded DHA-1 cephalosporinase. Int J Antimicrob Agents 35(3):265–268PubMedCrossRef Cuzon G, Naas T, Guibert M, Nordmann P (2010) In vivo selection of imipenem-resistant Klebsiella pneumoniae producing extended-spectrum beta-lactamase CTX-M-15 and plasmid-encoded DHA-1 cephalosporinase. Int J Antimicrob Agents 35(3):265–268PubMedCrossRef
7.
Zurück zum Zitat Chudácková E, Bergerová T, Fajfrlík K, Cervená D, Urbásková P, Empel J, Gniadkowski M, Hrabák J (2010) Carbapenem-nonsusceptible strains of Klebsiella pneumoniae producing SHV-5 and/or DHA-1 beta-lactamases in a Czech hospital. FEMS Microbiol Lett 309(1):62–70PubMed Chudácková E, Bergerová T, Fajfrlík K, Cervená D, Urbásková P, Empel J, Gniadkowski M, Hrabák J (2010) Carbapenem-nonsusceptible strains of Klebsiella pneumoniae producing SHV-5 and/or DHA-1 beta-lactamases in a Czech hospital. FEMS Microbiol Lett 309(1):62–70PubMed
8.
Zurück zum Zitat Mena A, Plasencia V, García L, Hidalgo O, Ayestarán JI, Alberti S, Borrell N, Pérez JL, Oliver A (2006) Characterization of a large outbreak by CTX-M-1-producing Klebsiella pneumoniae and mechanisms leading to in vivo carbapenem resistance development. J Clin Microbiol 44(8):2831–2837PubMedCrossRef Mena A, Plasencia V, García L, Hidalgo O, Ayestarán JI, Alberti S, Borrell N, Pérez JL, Oliver A (2006) Characterization of a large outbreak by CTX-M-1-producing Klebsiella pneumoniae and mechanisms leading to in vivo carbapenem resistance development. J Clin Microbiol 44(8):2831–2837PubMedCrossRef
9.
Zurück zum Zitat Gröbner S, Linke D, Schütz W, Fladerer C, Madlung J, Autenrieth IB, Witte W, Pfeifer Y (2009) Emergence of carbapenem-non-susceptible extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates at the university hospital of Tübingen, Germany. J Med Microbiol 58(Pt 7):912–922PubMedCrossRef Gröbner S, Linke D, Schütz W, Fladerer C, Madlung J, Autenrieth IB, Witte W, Pfeifer Y (2009) Emergence of carbapenem-non-susceptible extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates at the university hospital of Tübingen, Germany. J Med Microbiol 58(Pt 7):912–922PubMedCrossRef
10.
Zurück zum Zitat Lartigue MF, Poirel L, Poyart C, Réglier-Poupet H, Nordmann P (2007) Ertapenem resistance of Escherichia coli. Emerg Infect Dis 13(2):315–317PubMedCrossRef Lartigue MF, Poirel L, Poyart C, Réglier-Poupet H, Nordmann P (2007) Ertapenem resistance of Escherichia coli. Emerg Infect Dis 13(2):315–317PubMedCrossRef
11.
Zurück zum Zitat Leavitt A, Chmelnitsky I, Colodner R, Ofek I, Carmeli Y, Navon-Venezia S (2009) Ertapenem resistance among extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae isolates. J Clin Microbiol 47(4):969–974PubMedCrossRef Leavitt A, Chmelnitsky I, Colodner R, Ofek I, Carmeli Y, Navon-Venezia S (2009) Ertapenem resistance among extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae isolates. J Clin Microbiol 47(4):969–974PubMedCrossRef
12.
Zurück zum Zitat Endimiani A, Perez F, Bajaksouzian S, Windau AR, Good CE, Choudhary Y, Hujer AM, Bethel CR, Bonomo RA, Jacobs MR (2010) Evaluation of updated interpretative criteria for categorizing Klebsiella pneumoniae with reduced carbapenem susceptibility. J Clin Microbiol 48(12):4417–4425PubMedCrossRef Endimiani A, Perez F, Bajaksouzian S, Windau AR, Good CE, Choudhary Y, Hujer AM, Bethel CR, Bonomo RA, Jacobs MR (2010) Evaluation of updated interpretative criteria for categorizing Klebsiella pneumoniae with reduced carbapenem susceptibility. J Clin Microbiol 48(12):4417–4425PubMedCrossRef
13.
Zurück zum Zitat Martínez-Martínez L (2008) Extended-spectrum beta-lactamases and the permeability barrier. Clin Microbiol Infect 14(Suppl 1):82–89PubMedCrossRef Martínez-Martínez L (2008) Extended-spectrum beta-lactamases and the permeability barrier. Clin Microbiol Infect 14(Suppl 1):82–89PubMedCrossRef
14.
Zurück zum Zitat Machado E, Coque TM, Cantón R, Novais A, Sousa JC, Baquero F, Peixe L; Portuguese Resistance Study Group (2007) High diversity of extended-spectrum beta-lactamases among clinical isolates of Enterobacteriaceae from Portugal. J Antimicrob Chemother 60(6):1370–1374PubMedCrossRef Machado E, Coque TM, Cantón R, Novais A, Sousa JC, Baquero F, Peixe L; Portuguese Resistance Study Group (2007) High diversity of extended-spectrum beta-lactamases among clinical isolates of Enterobacteriaceae from Portugal. J Antimicrob Chemother 60(6):1370–1374PubMedCrossRef
15.
Zurück zum Zitat Poirel L, Barbosa-Vasconcelos A, Simões RR, Da Costa PM, Liu W, Nordmann P (2012) Environmental KPC-producing Escherichia coli isolates in Portugal. Antimicrob Agents Chemother 56(3):1662–1663PubMedCrossRef Poirel L, Barbosa-Vasconcelos A, Simões RR, Da Costa PM, Liu W, Nordmann P (2012) Environmental KPC-producing Escherichia coli isolates in Portugal. Antimicrob Agents Chemother 56(3):1662–1663PubMedCrossRef
16.
Zurück zum Zitat Clinical and Laboratory Standards Institute (CLSI) (2010) Performance standards for antimicrobial susceptibility testing; update. CLSI document M100–S20 June 2010 update. CLSI, Wayne, PA Clinical and Laboratory Standards Institute (CLSI) (2010) Performance standards for antimicrobial susceptibility testing; update. CLSI document M100–S20 June 2010 update. CLSI, Wayne, PA
17.
Zurück zum Zitat Novais A, Baquero F, Machado E, Cantón R, Peixe L, Coque TM (2010) International spread and persistence of TEM-24 is caused by the confluence of highly penetrating Enterobacteriaceae clones and an IncA/C2 plasmid containing Tn1696::Tn1 and IS5075-Tn21. Antimicrob Agents Chemother 54(2):825–834PubMedCrossRef Novais A, Baquero F, Machado E, Cantón R, Peixe L, Coque TM (2010) International spread and persistence of TEM-24 is caused by the confluence of highly penetrating Enterobacteriaceae clones and an IncA/C2 plasmid containing Tn1696::Tn1 and IS5075-Tn21. Antimicrob Agents Chemother 54(2):825–834PubMedCrossRef
18.
Zurück zum Zitat Doi Y, Potoski BA, Adams-Haduch JM, Sidjabat HE, Pasculle AW, Paterson DL (2008) Simple disk-based method for detection of Klebsiella pneumoniae carbapenemase-type beta-lactamase by use of a boronic acid compound. J Clin Microbiol 46(12):4083–4086PubMedCrossRef Doi Y, Potoski BA, Adams-Haduch JM, Sidjabat HE, Pasculle AW, Paterson DL (2008) Simple disk-based method for detection of Klebsiella pneumoniae carbapenemase-type beta-lactamase by use of a boronic acid compound. J Clin Microbiol 46(12):4083–4086PubMedCrossRef
19.
Zurück zum Zitat Galani I, Rekatsina PD, Hatzaki D, Plachouras D, Souli M, Giamarellou H (2008) Evaluation of different laboratory tests for the detection of metallo-beta-lactamase production in Enterobacteriaceae. J Antimicrob Chemother 61(3):548–553PubMedCrossRef Galani I, Rekatsina PD, Hatzaki D, Plachouras D, Souli M, Giamarellou H (2008) Evaluation of different laboratory tests for the detection of metallo-beta-lactamase production in Enterobacteriaceae. J Antimicrob Chemother 61(3):548–553PubMedCrossRef
20.
Zurück zum Zitat Poirel L, Castanheira M, Carrër A, Rodriguez CP, Jones RN, Smayevsky J, Nordmann P (2011) OXA-163, an OXA-48-related class D beta-lactamase with extended activity toward expanded-spectrum cephalosporins. Antimicrob Agents Chemother 55(6):2546–2551PubMedCrossRef Poirel L, Castanheira M, Carrër A, Rodriguez CP, Jones RN, Smayevsky J, Nordmann P (2011) OXA-163, an OXA-48-related class D beta-lactamase with extended activity toward expanded-spectrum cephalosporins. Antimicrob Agents Chemother 55(6):2546–2551PubMedCrossRef
21.
Zurück zum Zitat Ellington MJ, Kistler J, Livermore DM, Woodford N (2007) Multiplex PCR for rapid detection of genes encoding acquired metallo-beta-lactamases. J Antimicrob Chemother 59(2):321–322PubMedCrossRef Ellington MJ, Kistler J, Livermore DM, Woodford N (2007) Multiplex PCR for rapid detection of genes encoding acquired metallo-beta-lactamases. J Antimicrob Chemother 59(2):321–322PubMedCrossRef
22.
Zurück zum Zitat Antunes P, Coque TM, Peixe L (2010) Emergence of an IncIγ plasmid encoding CMY-2 β-lactamase associated with the international ST19 OXA-30-producing β-lactamase Salmonella typhimurium multidrug-resistant clone. J Antimicrob Chemother 65(10):2097–2100. doi:10.1093/jac/dkq293 PubMedCrossRef Antunes P, Coque TM, Peixe L (2010) Emergence of an IncIγ plasmid encoding CMY-2 β-lactamase associated with the international ST19 OXA-30-producing β-lactamase Salmonella typhimurium multidrug-resistant clone. J Antimicrob Chemother 65(10):2097–2100. doi:10.​1093/​jac/​dkq293 PubMedCrossRef
23.
Zurück zum Zitat Higgins PG, Lehmann M, Seifert H (2010) Inclusion of OXA-143 primers in a multiplex polymerase chain reaction (PCR) for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 35(3):305PubMedCrossRef Higgins PG, Lehmann M, Seifert H (2010) Inclusion of OXA-143 primers in a multiplex polymerase chain reaction (PCR) for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 35(3):305PubMedCrossRef
24.
Zurück zum Zitat Poirel L, Héritier C, Tolün V, Nordmann P (2004) Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob Agents Chemother 48(1):15–22PubMedCrossRef Poirel L, Héritier C, Tolün V, Nordmann P (2004) Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob Agents Chemother 48(1):15–22PubMedCrossRef
25.
Zurück zum Zitat Poirel L, Le Thomas I, Naas T, Karim A, Nordmann P (2000) Biochemical sequence analyses of GES-1, a novel class A extended-spectrum beta-lactamase, and the class 1 integron In52 from Klebsiella pneumoniae. Antimicrob Agents Chemother 44(3):622–632PubMedCrossRef Poirel L, Le Thomas I, Naas T, Karim A, Nordmann P (2000) Biochemical sequence analyses of GES-1, a novel class A extended-spectrum beta-lactamase, and the class 1 integron In52 from Klebsiella pneumoniae. Antimicrob Agents Chemother 44(3):622–632PubMedCrossRef
26.
Zurück zum Zitat D’Andrea MM, Nucleo E, Luzzaro F, Giani T, Migliavacca R, Vailati F, Kroumova V, Pagani L, Rossolini GM (2006) CMY-16, a novel acquired AmpC-type beta-lactamase of the CMY/LAT lineage in multifocal monophyletic isolates of Proteus mirabilis from northern Italy. Antimicrob Agents Chemother 50(2):618–624PubMedCrossRef D’Andrea MM, Nucleo E, Luzzaro F, Giani T, Migliavacca R, Vailati F, Kroumova V, Pagani L, Rossolini GM (2006) CMY-16, a novel acquired AmpC-type beta-lactamase of the CMY/LAT lineage in multifocal monophyletic isolates of Proteus mirabilis from northern Italy. Antimicrob Agents Chemother 50(2):618–624PubMedCrossRef
27.
Zurück zum Zitat Bert F, Branger C, Lambert-Zechovsky N (2002) Identification of PSE and OXA beta-lactamase genes in Pseudomonas aeruginosa using PCR-restriction fragment length polymorphism. J Antimicrob Chemother 50(1):11–18PubMedCrossRef Bert F, Branger C, Lambert-Zechovsky N (2002) Identification of PSE and OXA beta-lactamase genes in Pseudomonas aeruginosa using PCR-restriction fragment length polymorphism. J Antimicrob Chemother 50(1):11–18PubMedCrossRef
28.
Zurück zum Zitat Carlone GM, Thomas ML, Rumschlag HS, Sottnek FO (1986) Rapid microprocedure for isolating detergent-insoluble outer membrane proteins from Haemophilus species. J Clin Microbiol 24(3):330–332PubMed Carlone GM, Thomas ML, Rumschlag HS, Sottnek FO (1986) Rapid microprocedure for isolating detergent-insoluble outer membrane proteins from Haemophilus species. J Clin Microbiol 24(3):330–332PubMed
29.
Zurück zum Zitat Coelho A, González-López JJ, Miró E, Alonso-Tarrés C, Mirelis B, Larrosa MN, Bartolomé RM, Andreu A, Navarro F, Johnson JR, Prats G (2010) Characterisation of the CTX-M-15-encoding gene in Klebsiella pneumoniae strains from the Barcelona metropolitan area: plasmid diversity and chromosomal integration. Int J Antimicrob Agents 36(1):73–78PubMedCrossRef Coelho A, González-López JJ, Miró E, Alonso-Tarrés C, Mirelis B, Larrosa MN, Bartolomé RM, Andreu A, Navarro F, Johnson JR, Prats G (2010) Characterisation of the CTX-M-15-encoding gene in Klebsiella pneumoniae strains from the Barcelona metropolitan area: plasmid diversity and chromosomal integration. Int J Antimicrob Agents 36(1):73–78PubMedCrossRef
30.
Zurück zum Zitat Woodford N, Turton JF, Livermore DM (2011) Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance. FEMS Microbiol Rev 35(5):736–755PubMedCrossRef Woodford N, Turton JF, Livermore DM (2011) Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance. FEMS Microbiol Rev 35(5):736–755PubMedCrossRef
31.
Zurück zum Zitat Orsi GB, García-Fernández A, Giordano A, Venditti C, Bencardino A, Gianfreda R, Falcone M, Carattoli A, Venditti M (2011) Risk factors and clinical significance of ertapenem-resistant Klebsiella pneumoniae in hospitalised patients. J Hosp Infect 78(1):54–58PubMedCrossRef Orsi GB, García-Fernández A, Giordano A, Venditti C, Bencardino A, Gianfreda R, Falcone M, Carattoli A, Venditti M (2011) Risk factors and clinical significance of ertapenem-resistant Klebsiella pneumoniae in hospitalised patients. J Hosp Infect 78(1):54–58PubMedCrossRef
32.
Zurück zum Zitat Lee MY, Ko KS, Kang CI, Chung DR, Peck KR, Song JH (2011) High prevalence of CTX-M-15-producing Klebsiella pneumoniae isolates in Asian countries: diverse clones and clonal dissemination. Int J Antimicrob Agents 38(2):160–163PubMedCrossRef Lee MY, Ko KS, Kang CI, Chung DR, Peck KR, Song JH (2011) High prevalence of CTX-M-15-producing Klebsiella pneumoniae isolates in Asian countries: diverse clones and clonal dissemination. Int J Antimicrob Agents 38(2):160–163PubMedCrossRef
33.
Zurück zum Zitat Yan JJ, Wu JJ, Lee CC, Ko WC, Yang FC (2010) Prevalence and characteristics of ertapenem-nonsusceptible Escherichia coli in a Taiwanese university hospital, 1999 to 2007. Eur J Clin Microbiol Infect Dis 29(11):1417–1425PubMedCrossRef Yan JJ, Wu JJ, Lee CC, Ko WC, Yang FC (2010) Prevalence and characteristics of ertapenem-nonsusceptible Escherichia coli in a Taiwanese university hospital, 1999 to 2007. Eur J Clin Microbiol Infect Dis 29(11):1417–1425PubMedCrossRef
34.
Zurück zum Zitat Mammeri H, Guillon H, Eb F, Nordmann P (2010) Phenotypic and biochemical comparison of the carbapenem-hydrolyzing activities of five plasmid-borne AmpC beta-lactamases. Antimicrob Agents Chemother 54(11):4556–4560PubMedCrossRef Mammeri H, Guillon H, Eb F, Nordmann P (2010) Phenotypic and biochemical comparison of the carbapenem-hydrolyzing activities of five plasmid-borne AmpC beta-lactamases. Antimicrob Agents Chemother 54(11):4556–4560PubMedCrossRef
Metadaten
Titel
Spread of an OmpK36-modified ST15 Klebsiella pneumoniae variant during an outbreak involving multiple carbapenem-resistant Enterobacteriaceae species and clones
verfasst von
Â. Novais
C. Rodrigues
R. Branquinho
P. Antunes
F. Grosso
L. Boaventura
G. Ribeiro
L. Peixe
Publikationsdatum
01.11.2012
Verlag
Springer-Verlag
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 11/2012
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-012-1665-z

Weitere Artikel der Ausgabe 11/2012

European Journal of Clinical Microbiology & Infectious Diseases 11/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.